RxDoctor Payments Data

Benjamin Johnson, MD

Otolaryngology · Oshkosh, WINPI 1508420647

Payments from drug & device makers

What this record shows

Inspire Medical Systems, Inc. accounts for 66.5% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $1,272 and has fallen 62.0% since, to $483 in 2025.

$2,114in general payments, 2019–2025

Across 36 payments — averaging $58.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • Stryker$226
  • Aerin Medical Inc.$153
  • Medtronic$136
  • Regeneron Healthcare Solutions, Inc.$96
  • Biotissue Holdings Inc.$37
  • plus $61 from 2 others

What the payments were for

  • Travel & lodging$94945%
  • Food & beverage$1,16455%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,114 in reported general payments places this provider in the 80th percentile of 168 otolaryngology providers in Wisconsin.

See all otolaryngology providers in Wisconsin

Medicare billing

Part B allowed, 2024
$12,895
Medicare patients
48
Services billed
98

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron12$5,087
Omeprazole34$509

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Oshkosh

See the full list for Wisconsin

Where these figures come from

Is this you, or does something look wrong? →